Costs associated with cardiovascular disease create a significant burden for society and they seem to be globally underestimated

Abstract

Get full access to this article

View all access options for this article.

References

Roth

Johnson

Abajobir

et al.

Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol 2017; 70: 1–25.

Wilkins E, Wilson L, Wickramasinghe K, et al. European Cardiovascular Disease Statistics 2017. Brussels: European Heart Network, 2017.

Kotseva

Gerlier

Sidelnikov

et al.

Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Europe. Eur J Prev Cardiol. 2019; 26: 1150–1157.

Gordois

Toth

Quek

et al.

Productivity losses associated with cardiovascular disease: a systematic review. Expert Rev Pharmacoecon Outcomes Res 2016; 16: 759–769.

Kotseva

De Backer

De Bacquer

et al.

Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry. Eur J Prev Cardiol. 2019; 26: 824–835.

Piepoli

Corra

Adamopoulos

et al.

Secondary prevention in the clinical management of patients with cardiovascular diseases. Core components, standards and outcome measures for referral and delivery: a policy statement from the cardiac rehabilitation section of the European Association for Cardiovascular Prevention and Rehabilitation. Endorsed by the Committee for Practice Guidelines of the European Society of Cardiology. Eur J Prev Cardiol 2014; 21: 664–681.

Kotseva

Wood

De Bacquer

. EUROASPIRE investigators. Determinants of participation and risk factor control according to attendance in cardiac rehabilitation programmes in coronary patients in Europe: EUROASPIRE IV survey. Eur J Prev Cardiol 2018; 25: 1242–1251.